StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Leqvio Global Growth in Constant Currencies by Quarter

Leqvio Global Growth in Constant Currencies (% cc) (%)

QuarterlyAnnual

Novartis Leqvio Global Growth in Constant Currencies: 63.0% in Q3 2026, up 9.0 pts from a year earlier.

Latest, Q3 2026
63.0%
Period ended Sep 30, 2026
Change on a year earlier
+9.0 pts
54.0% in Q3 2025
History
14 quarters
Since Q2 2023
Sources
14
Documents cited below

Where the Q3 2026 figure comes from

“|| Leqvio | 506 | 308 | 64 | 63”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLeqvio Global Growth in Constant Currencies (% cc) (%)Year on yearSource
Q3 2026Sep 30, 202663.0%+9.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202659.0%-2.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202669.0%-3.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202546.0%-37.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202554.0%-65.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202561.0%-73.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 202572.0%-67.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202483.0%-107.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 2024119.0%-46.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 2024134.0%-115.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 2024139.0%–Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 2023190.0%–Novartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 2023165.0%–Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 2023249.0%–Novartis Form 6-K (0001370368-23-000059) ↗

Cite this data

StockData. (2026). Novartis Leqvio Global Growth in Constant Currencies (%), quarterly Q2 2023–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-leqvio-yoy-cc-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.